In vitro cytotoxicity of 211at-astatide and 131I- iodide to glioma tumor cells expressing the sodium/iodide symporter

Journal of Nuclear Medicine

Volumn 44, Issue 11, 2003, Pages 1827-1838

  Carlin, Sean ^a   Akabani, Gamal ^a   Zalutsky, Michael R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTATINE 211; IODINE 131; ASTATINE; COTRANSPORTER; RADIOACTIVE IODINE; SODIUM IODIDE SYMPORTER;

ABSORPTION; ARTICLE; CALCULATION; CANCER THERAPY; COLONY FORMING UNIT; CORRELATION COEFFICIENT; CYTOTOXICITY; GENETIC TRANSFECTION; GLIOMA; GLIOMA CELL; HUMAN; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; CELL SURVIVAL; GENETICS; PATHOLOGY; PHYSIOLOGY; RADIATION EXPOSURE; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ASTATINE; CELL LINE, TUMOR; CELL SURVIVAL; GLIOMA; HUMANS; IODINE RADIOISOTOPES; RADIATION DOSAGE; SYMPORTERS; TISSUE DISTRIBUTION; TRANSFECTION;

EID: 0642376392     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Filetti S, Bidart JM, Arturi F, et al. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism. Eur J Endocrinol 1999;141:443-457.
2. Chung JK. Sodium iodide symporter: its role in nuclear medicine J Nucl Med. 2002;43:1188-1200.
3. Mandell RB, Mandell LZ, Link CJ Jr. Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res 1999;59:661-668.
4. Carlin S, Cunningham SH, Boyd M, et al. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two- and three-dimensional models. Cancer Gene Ther. 2000;7:1529-1536.
5. - symporter gene. Endocrinology, 1997;138:4493-4496.
6. Boland A, Magnon C, Filetti S, et al. Transposition of the thyroid iodide uptake and organification system in nonthyroid tumor cells by adenoviral vector-mediated gene transfers. Thyroid. 2002;12:19-26
7. Hall EJ. Radiobiology for the Radiologist 3rd ed Philadelphia, PA: JB Lippincott; 1988.
8. Spitzweg C, O'Connor MK, Bergert ER, et al. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter. Cancer Res. 2000;60:6526-6530
9. - symporters for radioiodide concentrator gene therapy. J Nucl Med 2000;41:1898-1904.
10. Cho JY, Shen DH, Yang W, et al. In vivo imaging and radioiodine therapy following sodium iodide symporter gene transfer in animal model of intracerebral gliomas Gene Ther. 2002;9:1139-1145
11. O'Donoghue JA, Bardies M, Wheldon TE Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides J Nucl Med. 1995;36:1902-1909.
12. 211At]astatide accumulation in normal tissues: preliminary evaluation of seven potential compounds Nucl Med Biol. 1998;25:351-357
13. 131I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line. J Clin Endocrinol Metab. 2002;87:1247-1253
14. Dadachova E, Bouzahzah B, Zuckier LS, et al. Rhenium-188 as an alternative to iodine-131 for treatment of breast tumors expressing the sodium/iodide symporter (NIS). Nucl Med Biol. 2002;29:13-18
15. Kampf G. Induction of DNA double-strand breaks by ionizing radiation of different quality and their relevance for cell inactivation. Radiobiol Radiother (Berl). 1988;29:631-658.
16. 211At]astatide in NIS-transfected human cancer cells Nucl Med Biol. 2002;29:729-739.
17. Akabani G. Absorbed dose calculations in Haversian canals for several beta-emitting radionuclides. J Nucl Med. 1993;34:1361-1366
18. Akabani G, Hawkins WG, Eckblade MB, et al. Patient-specific dosimetry using quantitative SPECT imaging and three-dimensional discrete Fourier transform convolution. J Nucl Med. 1997;38:308-314.
19. Akabani G, Poston JW Sr. Absorbed dose calculations to blood and blood vessels for internally deposited radionuclides. J Nucl Med. 1991;32:830-834.
20. Akabani G, Kennel SJ, Zalutsky MR Microdosimetric analysis of α-particle-emitting targeted radiotherapeutics using histological images. J Nucl Med. 2003;44:792-805.
21. Petrith T, Helmeke HJ, Meyer GJ, et al. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter. Eur J Nucl Med Mol Imaging. 2002;29:842-854.
22. 211At]astatobenzylguanidine on human neuroblastoma cells. Cancer Res. 1994;54:5414-5419
23. Humm JL A microdosimetric model of astatine-211 labeled antibodies for radioimmunotherapy. Int J Radiat Oncol Biol Phys. 1987;13:1767-1773
24. Min JJ, Chung JK, Lee YJ, et al. In vitro and in vivo characteristics of a human colon cancer cell line, SNU-C5N, expressing sodium-iodide symporter. Nucl Med Biol 2002;29:537-545.
25. La Perle KM, Shen D, Buckwalter TL, et al. In vivo expression and function of the sodium iodide symporter following gene transfer in the MATLyLu rat model of metastatic prostate cancer Prostate. 2002;50:170-178.
26. 99mTc- pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues. Nucl Med Biol 2001;28:829-834.
27. Groot-Wassink T, Aboagye EO, Glaser M, et al. Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene Hum Gene Ther. 2002;13:1723-1735.
28. Zalutsky MR, Vaidyanathan G. Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy. Curr Pharm Des 2000;6:1433-1455.
29. Cobb LM, Harrison A, Dudley NE, et al. Relative concentration of astatine-211 and iodine-125 by human fetal thyroid and carcinoma of the thyroid in nude mice Radiother Oncol 1988;13:203-209.
30. 211At alpha-particle radiotherapy for undifferentiated thyroid cancer Acta Radiol Suppl. 1991;376:174-175.
31. - symporter gene in human thyroid tumors. a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab. 1999;84:3228-3234.
32. 125I-transport in porcine thyroid epithelial cells cultured in bicameral chambers. Nucl Med Biol. 2001;28:41-50.
33. Hamilton JG AC, Garrison WM, Scott KG. The accumulation, metabolism and biological effects of astatine in rats and monkeys. In: TDa WE, Anderson HH. eds University of California Publications in Pharmacology. Vol. 2 Los Angeles, CA: University of California Press, 1953:283-344.